January 10, 2020January 10, 2020

Keytruda, Imprime PGG Combo Increases Overall Survival in Metastatic Triple-negative BC, Data Show

News

Treatment with Biothera Pharmaceutical‘s Imprime PGG appears to increase the sensitivity of chemotherapy-resistant metastatic triple-negative breast cancers (mTNBC) to the immune checkpoint inhibitor Keytruda (pembrolizumab), interim data from a Phase 2 study ... Read more

July 17, 2019

Trilaciclib-Chemo Combo Extends Lives of Triple-negative Breast Cancer Patients, Preliminary Phase 2 Findings Show

News

Trilaciclib, a treatment that protects the bone marrow from the damaging effects of chemotherapy, significantly extends the lives of women with metastatic triple-negative breast cancer receiving a chemotherapy regimen of ... Read more